The Trump administration is currently looking into a U.S.-funded biological laboratory in Ukraine, previously criticized by Tulsi Gabbard, the Director of National Intelligence, who called it “treasonous” after raising concerns about it.
Background
In a video statement from 2022, Gabbard highlighted the existence of “25 to 30 U.S.-funded biolabs in Ukraine,” asserting that these facilities were researching harmful pathogens. She expressed a sense of urgency regarding the need to shut these labs down to mitigate risks of breaches and to destroy stored pathogens.
Gabbard had faced backlash from various quarters after sharing a video involving then-Deputy Secretary of State Victoria Nuland, who had been involved in matters related to Ukraine. Nuland addressed the Senate, confirming that “Ukraine has biological research facilities” and expressed worries that the Russian military might attempt to seize control of the research materials there. A pointed exchange with Senator Marco Rubio suggested that, should there be any biological or chemical incidents, blame would likely be directed at Russia.
Following Nuland’s comments, Avril Haines, then-Director of National Intelligence, affirmed that Ukraine operates over a dozen biolabs focused on biological defense. The U.S. provided support regarding biosafety, yet there were concerns about potential misuse, admitting that some materials could still be dangerous despite not being intended for weaponry.
The Pentagon acknowledged that around $200 million had been invested in Ukraine since 2005 under the Biological Threat Reduction Program, which aimed to support various laboratory and medical facilities in the country.
The Biden administration took a different stance, with Gabbard’s statements being termed as “Russian false propaganda” by some officials, suggesting they could have dire consequences.
Later on, Gabbard remained firm against the criticisms, dubbing them “defamatory” in nature.
Current Developments
Gabbard is now at the helm of a study recommended by the government back in 2022, aimed at investigating over 120 biolabs funded by U.S. taxpayers abroad. Reports suggest her team will look to pinpoint the locations of these labs, the pathogens they house, and the kind of research being conducted, especially regarding dangerous gain-of-function experiments.
“The COVID-19 pandemic illustrated the devastating global impact of dangerous pathogen research,” Gabbard stated, criticizing various political figures and medical experts for allegedly misleading the public about the reality of U.S.-funded biolabs and intimidating whistleblowers.
Authorities have acknowledged that more than 40 of these labs under scrutiny are in Ukraine, and could be vulnerable amidst the ongoing conflict. Some officials from the Trump administration argue that the Biden administration’s conflicting statements about these biolabs form a strategy intended to manage domestic narratives, countering external criticisms with misinformation.
For instance, a State Department statement in March 2022 distinctly claimed, “The United States does not own or operate any chemical or biological laboratories in Ukraine,” while maintaining that they were engaged in chemical and biological weapon activities, rather than collaborative research.
Army Secretary Pete Hegseth asserted that taxpayer money was funneled into risky research and kept concealed from the public during the previous administration. He added that the current administration, led by President Trump, is committed to addressing these significant oversights.
